-
Diagnostics World News | Efforts to use digital endpoints to modernize clinical trials have been slowed by an assortment of challenges. But the field will be getting a big push in the right direction in another few months when the first hard evidence will be published demonstrating digital endpoints can live up to their promise of delivering smaller, speedier trials.
Feb 16, 2023
-
Diagnostics World News | Researchers at Harvard University and Brigham and Women’s Hospital, along with collaborators from Bogazici University in Turkey, have revealed new technology intended to help make timely decisions during surgery. Their method uses artificial intelligence to enhance the image quality of frozen tissue samples in hopes of improving diagnostic speed and accuracy.
Feb 14, 2023
-
Diagnostics World News | Researchers at Duke University have come up with the new “best-in-class” systemic biomarker predictive of clinically relevant knee osteoarthritis that significantly outperforms the top-rated urine test when it comes to recognizing disease progression. Development of the targeted multiple reaction monitoring proteomic panel has been a 12-year labor of love for the team.
Feb 9, 2023
-
Diagnostics World News | Researchers in Germany have developed a series of innovative solutions for probing the body more broadly and deeply for early pathological signs of diseases ranging from metabolic disorders and neurodegenerative diseases to cancer. Their novel technology, dubbed DISCO-MS, does spatial proteomics in three-dimensional (3D) intact specimens using a combination of whole-organ and whole-organism clearing and imaging, deep-learning-based image analysis, robotic tissue extraction, and ultrahigh-sensitivity mass spectrometry.
Feb 8, 2023
-
Diagnostics World News | Research scientists at Indiana University–Purdue University Indianapolis and Regenstrief Institute have developed a “passive digital marker” (PDM), powered by machine learning, to help identify people at risk for Alzheimer’s disease and related dementias at an earlier stage in primary care settings. Application of the PDM will now be tested in the real world in a pair of pragmatic randomized controlled trials.
Feb 7, 2023